These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 276621)

  • 1. Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen.
    Williams GM; Watanabe K
    J Natl Cancer Inst; 1978 Jul; 61(1):113-21. PubMed ID: 276621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions.
    Watanabe K; Williams GM
    J Natl Cancer Inst; 1978 Nov; 61(5):1311-4. PubMed ID: 280716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation.
    Hirota N; Williams GM
    Cancer Res; 1982 Jun; 42(6):2298-309. PubMed ID: 7074612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action.
    Furuya K; Maeura Y; Williams GM
    Toxicol Pathol; 1984; 12(2):136-42. PubMed ID: 11478314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure.
    Hirota N; Williams GM
    J Natl Cancer Inst; 1979 Nov; 63(5):1257-65. PubMed ID: 291752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of early appearing, carcinogen-induced liver lesions to iron accumulation.
    Williams GM; Klaiber M; Parker SE; Farber E
    J Natl Cancer Inst; 1976 Jul; 57(1):157-65. PubMed ID: 1003498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
    Katayama S; Ohmori T; Maeura Y; Croci T; Williams GM
    J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of abnormality in glycogen storing capacity and other histochemical phenotypic changes in carcinogen-induced hepatocellular preneoplastic lesions in rats.
    Hirota N; Yokoyama T
    Acta Pathol Jpn; 1985 Sep; 35(5):1163-79. PubMed ID: 3002120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis.
    Hirota N; Williams GM
    Am J Pathol; 1979 May; 95(2):317-28. PubMed ID: 222150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes.
    Custer RP; Sorof S
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6738-42. PubMed ID: 6593726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased fibronectin in rat liver altered foci and adenomas induced by N-2-fluorenylacetamide.
    Maruyama H; Tanaka T; Gebhardt R; Berghem L; Williams GM
    Lab Invest; 1988 Jun; 58(6):630-5. PubMed ID: 3379912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential functional and morphological alterations during hepatocarcinogenesis induced in rats by feeding of a low dose of 2-acetylaminofluorene.
    Stenbäck F; Gebhardt R; Sirma H; Garbay JM; Williams GM
    Toxicol Pathol; 1994; 22(6):620-32. PubMed ID: 7732279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
    Merritt WD; Richardson CL; Keenan TW; Morré DJ
    J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and enrichment of cells resistant to iron accumulation from carcinogen-induced rat liver altered foci.
    Mori H; Mu B; Williams GM
    Exp Mol Pathol; 1982 Aug; 37(1):101-10. PubMed ID: 6126392
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA content of liver cell nuclei of N-2-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci.
    Mori H; Tanaka T; Sugie S; Takahashi M; Williams GM
    J Natl Cancer Inst; 1982 Dec; 69(6):1277-82. PubMed ID: 6958905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular injury, hyperplasia and putative premalignancy in rats fed 2-acetylaminofluorene.
    Goldfarb S; Pugh TD; Koen H
    Adv Enzyme Regul; 1984; 22():123-36. PubMed ID: 6147961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effect of barbital on N-2-fluorenylacetamide-induced rat liver lesions.
    Mori H; Tanaka T; Nishikawa A; Takahashi M; Williams GM
    Gan; 1981 Oct; 72(5):798-801. PubMed ID: 7327380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear inclusions and other ultrastructural aspects in the liver of animals treated with n-2-acetylaminofluorene.
    Dobre MA; Moraru I; Cotutiu C; Moţoc F
    Pathol Eur; 1976; 11(1):63-8. PubMed ID: 934702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.
    Solt DB; Medline A; Farber E
    Am J Pathol; 1977 Sep; 88(3):595-618. PubMed ID: 18937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional markers and growth behavior of preneoplastic hepatocytes.
    Williams GM
    Cancer Res; 1976 Jul; 36(7 PT 2):2540-3. PubMed ID: 58721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.